FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/04/107515 [Registered on: 02/04/2026] Trial Registered Prospectively
Last Modified On: 02/04/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A Study to compare the effectiveness of two Ayurvedic Medicines Patola triphaladi Kashaya and Amrtavrishadi Kashaya in Urticaria 
Scientific Title of Study   A Comparative Clinical Trial to evaluate the effectiveness of Patola triphaladi Kashaya in comparison to Amrtavrishadi Kashaya in Urticaria 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr JEEVAN K G 
Designation  Research Scholar (PhD) 
Affiliation  Glocal College of Ayurvedic Medical Science and Research Centre 
Address  GLOCAL UNIVERSITY MIRZAPUR, SAHARANPUR, UTTARPRADESH,INDIA

Saharanpur
UTTAR PRADESH
247121
India 
Phone  9961993323  
Fax    
Email  jeevanjeevanss@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr JEEVAN K G 
Designation  Research Scholar (PhD) 
Affiliation  Glocal College of Ayurvedic Medical Science and Research Centre 
Address  GLOCAL UNIVERSITY MIRZAPUR, SAHARANPUR, UTTARPRADESH,INDIA

Saharanpur
UTTAR PRADESH
247121
India 
Phone  9961993323  
Fax    
Email  jeevanjeevanss@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr N VIMALA  
Designation  Professor 
Affiliation  Glocal College of Ayurvedic Medical Science and Research Centre 
Address  GLOCAL UNIVERSITY MIRZAPUR, SAHARANPUR, UTTARPRADESH,INDIA

Saharanpur
UTTAR PRADESH
247121
India 
Phone  9447006465  
Fax    
Email  drnvimalaajith@gmail.com  
 
Source of Monetary or Material Support  
GLOCAL UNIVERSITY MIRZAPUR, SAHARANPUR, UTTARPRADESH, 247121, INDIA  
GOVERNMENT AYURVEDA HOSPITAL OTTAPALAM,PALAKKAD, KERALA,679104 
 
Primary Sponsor  
Name  Dr JEEVAN K G 
Address  PhD Scholar, GLOCAL UNIVERSITY MIRZAPUR, SAHARANPUR, UTTARPRADESH, 247121, INDIA  
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr JEEVAN K G  Glocal College of Ayurvedic Medical Science and Research Centre  GLOCAL UNIVERSITY MIRZAPUR, SAHARANPUR, UTTARPRADESH, 247121, INDIA
Saharanpur
UTTAR PRADESH 
9961993323

jeevanjeevanss@gmail.com 
Dr JEEVAN K G  Government Ayurveda Hospital Ottapalam  Government Ayurveda Hospital Ottapalam, Palakkad,Kerala 679104
Palakkad
KERALA 
9961993323

jeevanjeevanss@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Glocal University Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L509||Urticaria, unspecified. Ayurveda Condition: SITAPITTAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Patola Triphaladi kashaya, Reference: Sahasrayoga, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 48(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 45 Days, anupAna/sahapAna: No, Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Amrtavrishadi Kashaya, Reference: Sahasrayoga, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 48(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 45 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patients with signs and symptoms of Urticaria

Both male and female participants between the age group of 18-70 presenting with less than 50 wheals along with and symptoms such as itching, rashes, dermatographism 
 
ExclusionCriteria 
Details  Participants on continuous allopathic medications for urticaria

Participants having history of anaphylaxis and urticarial vasculitis

Participants having drug allergy

Participants with uncontrolled systemic illness

Patients not co-operating with the study

Pregnant women and lactating mothers

Others dermatological conditions like contact dermatitis, allergic eczema, angioedema 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Change in severity of urticaria symptoms (itching, wheals,rashes,dermatographism)using a predefined symptom grading scale   from baseline to day 15, day 30, day 45 and day 60  
 
Secondary Outcome  
Outcome  TimePoints 
change in Urticaria Activity score   during baseline (Day 1-7), during treatment (Day 39 -45), and end of study (Day 53 -59) 
Change in serum IgE levels   from Baseline (Day 0) to day 60 
 
Target Sample Size   Total Sample Size="122"
Sample Size from India="122" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/04/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Urticaria is a common dermatological condition characterized by wheals, itching, and erythema. This study aims to evaluate the effectiveness of Patola triphaladi Kashaya compared to Amrtavrishadi Kashaya in managing urticaria. A total of 122 participants will be randomized into two groups and treated for 45 days with a follow-up of 15 days. Outcomes will be assessed using symptom grading scale, Urticaria Activity Score (UAS7), and serum IgE levels 
Close